Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CanadaBis CapitalTSXV:CANB EV-to-OCF is -4.22 as of Sep. 05, 2026. The stock has 6 warning signs investors should review. Among 1,006 Drug Manufacturers companies, CanadaBis Capital ranks better than 75.84% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, CanadaBis Capital's Enterprise Value is C$8.79 Mil.
CanadaBis Capital's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2025 was C$-2.08 Mil. Therefore, CanadaBis Capital's EV-to-OCF for today is -4.22.
The historical rank and industry rank for CanadaBis Capital's EV-to-OCF or its related term are showing as below:
TSXV:CANB'
s EV-to-OCF Range Over the Past 10 Years
Min: -1541.47 Med: -6.85 Max: 40.6
Current: -4.22
During the past 10 years, the highest EV-to-OCF of CanadaBis Capital was 40.60. The lowest was -1541.47. And the median was -6.85.
TSXV:CANB's EV-to-OCF is ranked better than 75.84% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 10.355
vs TSXV:CANB: -4.22
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CanadaBis Capital (TSXV:CANB) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CanadaBis Capital's PE Ratio (TTM) for today is calculated as:
CanadaBis Capital's share price for today is C$0.015.
CanadaBis Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CanadaBis Capital EV-to-OCF Related Terms
CanadaBis Capital EV-to-OCF Historical Data
* Premium members only.
The historical data trend for CanadaBis Capital's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:CANB vs STEK, GCAN, GRPS: EV-to-OCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanadaBis Capital EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where CanadaBis Capital's EV-to-OCF falls into.
CanadaBis Capital's current Enterprise Value is C$8.79 Mil.
CanadaBis Capital's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CanadaBis Capital (TSXV:CANB) has a EV-to-OCF of -4.22 as of Sep. 05, 2026. According to the industry distribution chart, CanadaBis Capital ranks #243 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 24.2%.
Is CanadaBis Capital's EV-to-OCF too high?
CanadaBis Capital's current EV-to-OCF is -4.22. Based on the distribution chart, CanadaBis Capital ranks #243 out of 1006 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does CanadaBis Capital's EV-to-OCF compare to STEK and GCAN?
According to the Drug Manufacturers industry distribution chart, CanadaBis Capital ranks #243 out of 1006 companies for EV-to-OCF. This places CanadaBis Capital in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 10.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.36, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current EV-to-OCF is -4.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current EV-to-OCF of -4.22. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current EV-to-OCF is -4.22. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current EV-to-OCF is -4.22 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CANB has been successfully added to your 
